Ocena substancji – wspólnotowy kroczący plan działań

Ocena substancji – wspólnotowy kroczący plan działań

Ocena substancji – wspólnotowy kroczący plan działań

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 22 marca 2024. Database contains 402 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
205-288-3
137-30-4
2012
Denmark
Potential endocrine disruptor
High RCR
Information requested
Details
215-222-5
1314-13-2
2017
Germany
Other hazard based concern
Consumer use
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
215-535-7
1330-20-7
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
203-545-4
108-05-4
2019
Latvia
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-944-3
7779-90-0
2013
Romania
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
246-677-8
25155-23-1
2014
Italy
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
237-159-2
13674-87-8
Germany
Potential endocrine disruptor
Withdrawn
Details
809-930-9
1330-78-5
2014
Netherlands
Suspected PBT/vPvB
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-028-2
-
2013
France
Suspected PBT/vPvB
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
222-020-0
3319-31-1
2012
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
202-908-4
101-02-0
2013
United Kingdom
Suspected CMR
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-112-2
115-86-6
2017
France
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-929-1
112-03-8
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
220-449-8
2768-02-7
2013
Sweden
Suspected Sensitiser
Exposure of sensitive populations
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
214-685-0
1185-55-3
2013
Sweden
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
222-182-2
3380-34-5
2012
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Follow-up
Details
202-924-1
101-20-2
2019
France
Suspected Reprotoxic
Potential endocrine disruptor
Wide dispersive use
Concluded
Details
204-800-2
126-73-8
2012
Hungary
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
484-450-7
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
203-625-9
108-88-3
2012
Finland
CMR
Other hazard based concern
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
236-675-5
13463-67-7
2018
France
Carcinogenic
Suspected Mutagenic
Other hazard based concern
Information requested
Details
231-302-2
7488-55-3
2016
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Concluded
Details
205-286-2
137-26-8
2014
Sweden
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
257-573-7
51981-21-6
2024
France
Suspected Carcinogenic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-726-8
109-99-9
2013
Germany
CMR
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-499-5
107-52-8
2024
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Ongoing
Details
204-825-9
127-18-4
2013
Latvia
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
210-382-2
614-45-9
2013
Italy
Sensitiser
Consumer use
Wide dispersive use
Concluded
Details
216-653-1
1634-04-4
2014
France
Potential endocrine disruptor
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
231-511-9
7601-89-0
2015
Germany
Suspected Carcinogenic
Potential endocrine disruptor
Other hazard based concern
Exposure of workers
Wide dispersive use
Concluded
Details
205-739-4
149-44-0
2026
Netherlands
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
231-890-0
7775-14-6
2016
Austria
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
231-836-6
7758-19-2
2019
Hungary
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
Wide dispersive use
Concluded
Details
204-857-3
127-68-4
Ireland
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Withdrawn
Details
BENZTRIAZOL UV ABSORBER BUK 4499; BUK 4499; UV ABSORBER BUK 4499
403-080-9
92484-48-5
2023
Spain
Suspected PMT/vPvM
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
231-131-3
7440-22-4
2014
Netherlands
Other hazard based concern
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
231-545-4
7631-86-9
2012
Netherlands
Other hazard based concern
Other exposure/risk based concern
Concluded
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Concluded
Details
700-579-6
-
2017
Netherlands
Suspected PBT/vPvB
Wide dispersive use
Concluded
Details
X4261
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
203-585-2
108-46-3
2016
Finland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-585-2
108-46-3
2019
France
Potential endocrine disruptor
High (aggregated) tonnage
Information requested
Details
264-848-5
64365-17-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
266-042-9
65997-13-9
2015
Finland
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
807-935-0
1244733-77-4
2022
Denmark
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Cumulative exposure
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-385-4
-
2021
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
938-828-8
-
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
947-768-1
-
2025
Netherlands
Suspected Mutagenic
Other hazard based concern
Exposure of workers
Wide dispersive use
Not started
Details
ADDITIV 104
412-780-3
1380226-46-9
France
Suspected PBT/vPvB
Concluded
Details
939-505-4
-
2023
France
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
ROBAC AS/100
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Concluded
Details
430-050-2
-
2017
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
700-161-3
-
2013
Netherlands
Suspected PBT/vPvB
Ongoing
Details
905-588-0
-
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
905-562-9
-
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
905-806-4
-
2015
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-337-2
-
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-241-0, 906-390-7
-
Italy
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
906-484-8
-
2015
Slovenia
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
907-745-9
-
2015
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
473-390-7
-
2016
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
701-263-0
-
2020
Denmark
Potential endocrine disruptor
Concluded
Details
915-730-3
-
2017
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Information requested
Details
905-459-9
-
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Not started
Details
EC No. 415-490-5 and 604-250-7
-
-
2016
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
264-120-7
63393-96-4
2017
Italy
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Concluded
Details
295-835-2
92129-33-4
2015
Italy
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
203-686-1
109-60-4
Ireland
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
202-307-7
94-13-3
2015
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Wide dispersive use
Concluded
Details
219-006-1
2312-35-8
2019
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Concluded
Details
422-270-2
163702-08-7
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Information requested
Details
231-760-3
7722-64-7
2017
France
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Concluded
Details
444-340-1
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
468-710-7
754-12-1
2012
Germany
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
262-975-0
61788-44-1
2014
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Cumulative exposure
Concluded
Details
701-251-5
-
2013
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
273-066-3
68937-41-7
2020
Netherlands
Potential endocrine disruptor
Suspected PBT/vPvB
Information requested
Details
272-486-4
68855-45-8
2016
France
CMR
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
310-154-3
121158-58-5
2018
Germany
Potential endocrine disruptor
Concluded
Details
284-325-5
84852-15-3
2014
Spain
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
271-867-2
68610-51-5
2016
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
203-632-7
108-95-2
2015
Denmark
Suspected Mutagenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
High RCR
Concluded
Details
201-344-6
81-33-4
Belgium
Suspected PBT/vPvB
Withdrawn
Details
204-500-1
121-82-4
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Withdrawn
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Follow-up
Details
200-752-1
71-41-0
2016
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
203-396-5
106-42-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-398-6
106-44-5
2015
United Kingdom
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
225-716-2
5026-74-4
Denmark
Suspected Mutagenic
Suspected Sensitiser
Consumer use
Exposure of workers
Withdrawn
Details
201-280-9
80-46-6
2014
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Concluded
Details
248-258-5
27138-31-4
2019
Latvia
Suspected Reprotoxic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
211-745-8
693-21-0
2016
Italy
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
High RCR
Concluded
Details
204-407-6
120-55-8
2019
Latvia
Suspected Reprotoxic
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
205-031-5
131-57-7
2014
Denmark
Potential endocrine disruptor
Cumulative exposure
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
271-846-8
68609-97-2
Ireland
Suspected Mutagenic
Sensitiser
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Withdrawn
Details
701-246-8
-
2025
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Not started
Details
701-463-8
-
2025
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Not started
Details
show/hide
Phenol, methylstyrenated EC / List no: 270-966-8 | CAS no: 68512-30-1
700-960-7
-
2012
Denmark
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
228-250-8
6197-30-4
2012
France
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
The complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isononanal. It consists predominantly of C6 olefins and paraffins and C9 alcohols and aldehydes and boiling in the range of approximately 110°C to 202°C (230°F to 396°F).
273-110-1
68938-03-4
2025
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Not started
Details
203-497-4
107-51-7
2015
Norway
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
220-260-0
2691-41-0
Hungary
Suspected Carcinogenic
Suspected Reprotoxic
Exposure of environment
Exposure of workers
Wide dispersive use
Withdrawn
Details
217-421-2
1843-05-6
2013
Italy
Potential endocrine disruptor
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-422-2
95-47-6
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
209-909-9
597-82-0
2016
Netherlands
Suspected PBT/vPvB
Follow-up
Details
1 - 2.5 moles ethoxylated
500-209-1
68412-54-4
2016
United Kingdom
Potential endocrine disruptor
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
202-049-5
91-20-3
2016
United Kingdom
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Concluded
Details
484-470-6
623-40-5
2022
Germany
Suspected Carcinogenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-870-9
100-61-8
2023
Poland
Suspected Carcinogenic
Suspected Mutagenic
Cumulative exposure
Exposure of workers
High RCR
Wide dispersive use
Conclusion under preparation
Details
203-777-6
110-54-3
2012
Germany
CMR
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
214-263-6
1118-46-3
2018
France
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
267-636-0
67905-17-3
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
629-767-5
1228186-18-2
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
201-983-0
90-30-2
2012
Germany
Suspected PBT/vPvB
Wide dispersive use
Concluded
Details
432-520-2
232938-43-1
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
221-374-3
3081-01-4
2012
Austria
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
223-055-4
3710-84-7
2019
Sweden
Suspected Carcinogenic
Suspected Mutagenic
Concluded
Details
225-625-8
4979-32-2
2013
Germany
Suspected CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
Exposure of workers
Wide dispersive use
Concluded
Details
251-118-6
32588-76-4
2017
Norway
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
221-375-9
3081-14-9
2012
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
show/hide
Tangled Multi-Walled Carbon Nanotubes EC / List no: 701-160-0 | CAS no: -
-
-
2019
Germany
Suspected Carcinogenic
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Wide dispersive use
Concluded
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
429-320-2
24748-23-0
2019
Netherlands
PBT/vPvB
Information requested
Details
203-624-3
108-87-2
2013
Finland
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-475-4
107-25-5
2018
Latvia
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Exposure of workers
Other exposure/risk based concern
Concluded
Details
204-317-7
119-36-8
2015
France
Suspected CMR
Consumer use
High (aggregated) tonnage
Concluded
Details
201-297-1
80-62-6
2014
France
Sensitiser
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
202-785-7
99-76-3
2014
France
CMR
Potential endocrine disruptor
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
200-659-6
67-56-1
2012
Poland
Suspected CMR
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
248-666-3
27813-02-1
2014
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
201-202-3
79-39-0
2016
Sweden
Other hazard based concern
Exposure of workers
Concluded
Details
203-571-6
108-31-6
2013
Austria
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
203-576-3
108-38-3
2015
Germany
Suspected CMR
Suspected Sensitiser
Consumer use
Cumulative exposure
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
247-722-4
26471-62-5
2012
Poland
CMR
Suspected PBT/vPvB
Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-584-7
108-45-2
2018
Latvia
Suspected Reprotoxic
Sensitiser
Exposure of workers
High (aggregated) tonnage
Concluded
Details
249-535-3
29253-36-9
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
275-702-5
71617-10-2
2016
Germany
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
250-610-8
31394-54-4
2012
Latvia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
IRGANOX L 118
404-800-4
118832-72-7
2014
Germany
Suspected PBT/vPvB
Concluded
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Follow-up
Details
206-019-2
288-32-4
2012
United Kingdom
CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-617-8
123-31-9
2012
Italy
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
701-057-0
-
Germany
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Withdrawn
Details
228-408-6
6259-76-3
2012
Netherlands
Suspected CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-492-7
107-46-0
2013
Norway
Suspected CMR
Consumer use
High (aggregated) tonnage
Information requested
Details
204-127-4
116-15-4
2015
Italy
Suspected CMR
High (aggregated) tonnage
Concluded
Details
931-274-8
-
2014
Slovenia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-626-1
98-00-0
2013
Poland
CMR
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
200-001-8
50-00-0
2013
France
CMR
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
272-902-4
68919-76-6
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
629-732-4
1224966-13-5
2015
Lithuania
Sensitiser
Exposure of sensitive populations
Exposure of workers
Concluded
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
211-063-0
628-96-6
2016
Italy
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-510-0
96-49-1
2018
Latvia
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-597-5
97-63-2
2014
Italy
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
204-399-4
120-47-8
Germany
Potential endocrine disruptor
Withdrawn
Details
404-740-9
115895-09-5
2016
Slovenia
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
941-303-6
-
2026
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
405-420-1
-
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
205-492-2
141-63-9
2015
Norway
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
206-354-4
330-54-1
2014
Finland
Potential endocrine disruptor
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
287-401-6
85507-79-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
248-948-6
28299-41-4
2014
Netherlands
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
229-912-9
6834-92-0
2015
Latvia
Suspected Reprotoxic
Consumer use
High (aggregated) tonnage
High RCR
Concluded
Details
231-673-0
7681-57-4
2014
Hungary
Suspected CMR
Exposure of environment
Exposure of sensitive populations
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
205-117-2
133-66-4
Italy
Suspected PBT/vPvB
Wide dispersive use
Withdrawn
Details
215-575-5
1332-77-0
2017
Lithuania
Reprotoxic
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
278-355-8
75980-60-8
Sweden
Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
212-791-1
870-08-6
2024
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Withdrawn
Details
212-783-8
868-85-9
2012
Netherlands
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
214-277-2
1119-40-0
2014
Poland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
210-871-0
624-92-0
2014
Germany
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
214-189-4
1112-39-6
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Withdrawn
Details
247-660-8
26401-35-4
2013
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
249-044-4
28472-97-1
2013
Italy
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
233-072-9
10028-22-5
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
270-877-4
68479-98-1
2016
Denmark
Suspected Mutagenic
Suspected Reprotoxic
Concluded
Details
201-550-6
84-66-2
2014
Germany
CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
200-467-2
60-29-7
2025
France
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
201-545-9
84-61-7
2017
Sweden
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Concluded
Details
200-838-9
75-09-2
2016
Italy
Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
High (aggregated) tonnage
Concluded
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
215-175-0
1309-64-4
2018
Germany
Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
205-016-3
131-17-9
2013
Spain
CMR
Consumer use
Wide dispersive use
Concluded
Details
234-042-8
10508-09-5
2015
Italy
Suspected Carcinogenic
Suspected Mutagenic
Exposure of workers
Wide dispersive use
Concluded
Details
203-733-6
110-05-4
2016
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
229-782-3
6731-36-8
2014
Germany
Suspected PBT/vPvB
Information requested
Details
203-956-9
112-30-1
2012
Italy
Other hazard based concern
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
205-491-7
141-62-8
2015
Norway
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
202-046-9
91-17-8
2012
Finland
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
201-248-4
80-08-0
2016
Germany
Potential endocrine disruptor
Concluded
Details
203-629-0
108-91-8
2016
Belgium
Reprotoxic
Exposure of environment
High (aggregated) tonnage
Concluded
Details
203-631-1
108-94-1
2016
Poland
Suspected Carcinogenic
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details

Export search results to: